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Hormones are  foremost  among the  many fac tors  cont ro l l ing  
mammary g land growth.  I t  is  we l l -es tab l ished that  es t rogens 
s t imula te  growth o f  the mammary duct  sys tem,  and the combinat ion 
o f  es t rogen and progesterone evoke fu l l  lobu lo-a lveo lar  deve lopment .  
These e f fec ts  are ,  however ,  dependent  on an in tac t  p i tu i ta ry .  
Large doses o f  pro lac t in  and growth hormone w i l l  a lso  s t imula te  
fu l l  mammary lobu lo-a lveo lar  deve lopment .  The ovar ies  are  not  
requ i red fo r  th is  e f fec t  (Ta lwalker  and Mei tes ,  1961) .  
Lactogenes is ,  the  appearance o f  secre tory  ac t iv i ty ,  i s  induced 
by  a  hormonal  combinat ion that  i s  d i f fe rent  f rom that  which g ives  
r ise  to  mammary g land growth.  The es t rogen-progesterone equ i l ib r ium 
dur ing most  o f  pregnancy is  thought  to  make the mammary g lands 
res is tant  to  the s t imula tory  e f fec ts  on the lac togen ic  complex .  
Th is  es t rogen-progesterone ra t io  inh ib i ts  the secre t ion  o f  p ro lac t in  
by the p i tu i ta ry  (Mei tes ,  1966)  and a lso  probab ly  o ther  const i tuents  
or Lhe lactogenic complex (Ford and Melampy, 1973). 
At  par tur i t ion  the fa l l  in  p lasma progesterone together  w i th  a 
temporary  r i se  in  es t rogen secre t ion  renders  the mammary g land 
recept ive  to  the lac togen ic  ac t ions o f  pro lac t in  and adrena l  
s tero ids .  P lasma concent ra t ions o f  pro lac t in  and g lucocor t ico ids  r ise  
dur ing la te  pregnancy.  Increased secre tory  ac t iv i ty  o f  the mammary 
ep i the l ium is  complementary  w i th  th is  r ise  in  lac togen ic  hormones.  
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Lactation can be initiated during early, mid- or late pregnancy 
in the rat with glucocorticoid injections (Talwalker et al., 1961). 
Better milk yields are obtained with the combination of prolactin 
and adrenal corticoids. Prolactin alone is ineffective in inducing 
lactation in pregnant rats. 
Plasma progesterone is inhibitory to lactogenesis during most 
of pregnancy partly due to its inhibitory effect on alpha-1actalbumin 
synthesis. Exogenous progesterone does not affect established 
lactation unless massive doses are administered (Barsantini and 
Masson, 1947). 
Endogenous estrogen does not inhibit lactogenesis or galacto-
poiesis in rats. However, physiological or pharmacological doses of 
estrogenic compounds suppress lactation in rats with intact ovaries. 
Only pharmacological doses of estrogen are inhibitory to lactation 
in ovariectomized rats. Physiological doses have no effect 
(Griffith and Turner, 1962). 
Estrogen-progesterone treatments inhibit lactational performance 
in both intact and ovariectomized rats. This hormonal combination 
is effective in both physiological and pharmacological doses. 
This investigation was conducted to determine whether gluco­
corticoids and prolactin, singly and in combination, would override 
the supression of lactation caused by estrogen-progesterone treat­
ments. Mammary gland proliferation was determined by DNA content and 
secretory activity by RNA content, RNA/DNA ratio and litter weight 
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gains. Attempts were made to relate changes in mammary development 
and synthetic activity with hormonal treatments. 
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LITERATURE REVIEW 
Mammary Gland Development and Growth 
Biochemical method of determi ning growth 
The most commonly used index of mammary gland growth is the 
determination of the DNA content of the gland. This procedure was 
first used on the mammary glands by Kirkham and Turner (1953). It 
was based on the concept set forth by Boivin and colleagues (1948) 
and Mirsky and Ris (1949) that the DNA content of cell nuclei is 
constant for all somatic cells of an organism. Subsequent studies 
(Griffith and Turner, 1959; Tucker and Reece, 1962) supported this 
basic premise. Nevertheless, others have suggested that DNA is 
not constant per cell nuclei (Sod-Moriah and Schmidt, 1968; Simpson 
and Schmidt, 1970). 
Turner (1970) re-examined the DNA procedures and concluded 
that the estimation of mammary gland growth by this method may be 
subject to some error involving the possible growth of connective 
tissue during pregnancy and lactation, but it is the only true 
quantitative estimate of mammary gland growth. Comparisons of the 
mammary gland area and DNA methods revealed that the two procedures 
correlate well (Munford, 1963; Nagasawa et al., 1966). Significant 
positivé correlations were obtained between the two procedures in 
mice 50-210 days old. This coincided with results of Sinha and 
Tucker (1966) who observed high correlation between area and DNA 
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content of mammary glands of 10-100 day old rats. 
Embryonic mammary development 
The mammary band is the first recognizable structure in the 
developing mammary gland of the rat and mouse. It appears on either 
side of the midline in 11 day old fetuses. By the 12th day the 
tissue near the mammary band has further thickened to form the 
mammary crest. Immediately five ectodermal thickenings appear in 
each mammary crest. These are the individual mammary anlagen, the 
mammary hillocks. Between the 13th and l4th days the mammary 
hillocks increase in volume and assume an almost spherical 
shape becoming the mammary buds, the primordia of the future mammary 
gland. In female fetuses, on day 15 the mammary bud sinks into the 
mesenchyme and elongates into a cord which begins to branch at the 
distal ends near term (Raynaud, 1961, 1971). 
Prepubera1 growth 
At birth, the mammary gland of the rat is fairly well-developed. 
Its ducts are dilated and ultrastructurally cells appear to be 
secretory (Ceriani et al., 1970). The total mammary gland area 
increases isometrically with the body surface until about the 22nd 
day when a phase of allometric growth ensues (Cowie, 1949). 
Using DNA content as a measure of gland growth. Sinha and 
Tucker (1966) found that the most rapid proliferation of ducts into 
the fatty pads occurred between days 23-40 of age. These results 
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concur with those of Myers (1916) and Nagasawa et al. (1967) who 
found an increase in the rudimentary duct system at four weeks 
after birth. This is about the same time that the rat ovary starts 
to secrete estrogen (Price, 1947). The adipose and connective 
tissue portions of the gland increase also at this time, and 
continue to increase whether or not ovariectomy is performed 
(Paape and Sinha, 1971). 
Ovariectomy on the 22nd day can prevent the onset of the 
allometric growth phase (Cowie, 1949). Normal allometric growth 
can be restored in the ovariectomized rat and mouse by suitable 
injections of estrogen (Silver, 1953; Flux, 195^). Estrogen then 
appeared to be the normal stimulus for the growth of the mammary 
ducts in the adolescent rat and mouse (Folly, 1956). 
Postpuberal growth 
After puberty, when the hormonal activities of the ovaries 
are established, the tissues of the mammary gland grow marked ly .  
ÂS A result of numerous studies kindled by Turner and Schultze 
(1931) and Astwood et al. (1937), estrogens are thought to 
stimulate growth of the duct system, whereas lobulo-alveolar develop­
ment depends on progesterone. 
Ancel and Bouin (1911) showed that the corpus luteum was 
responsible for lobulo-alveolar growth in the pseudopregnant 
rabbit. Later studies (Turner and Schultze, 1931) revealed that 
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physiological doses of progesterone had little or no mammogenic 
capability, but pharmacological doses would stimulate mammary 
growth in rats (Reece and Bivins, 1942). 
Estradiol benzoate treatment causes little mammary gland 
growth (Moon et al., 1959), even if treatments are extended for 
periods of up to 60 days (Panda and Turner, 1966). Estrogen 
treatments increase the rate of mammary gland DMA synthesis and 
increase the number of cells undergoing DNA replication 
(Bresciani, 1971). After some time, ovarian hormones may become 
inhibitory on the mammary epithelium (Panda and Turner, 1966). 
it is well established that both estrogen and progesterone 
together are more effective than either alone in promoting growth 
of all mammary gland tissues (Jacobsohn, 1961). The ratio of 
estrogen to progesterone and the absolute amount of each hormone 
present are important in determining the quantity and quality of 
mammary development. in the mouse and rat, the optimum ratios 
appear to be of the order of 1 part of estrogen to 1000 parts 
or more of progesterone (Elliot and Turner, 1953). 
Studies in hypophysectomized rats and guinea pigs showed 
that estrogens and progesterone were not effective in stimulating 
mammary growth in the absence of the pituitary gland (Gomez and 
Turner, 1937)- Major elucidation of the roles of the ovarian 
and pituitary hormones in mammogenesis came from studies on rats 
by Lyons and his colleagues (1958) and on mice by Nandi (1959). 
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They studied the effects of various combinations of ovarian and 
hypophysial hormones on mammary growth in young animals from 
which the pituitary, pituitary and ovaries or pituitary, ovaries 
and adrenals (triply operated) had been removed. Small variations 
in mammogenic responses were observed between the rat and mice, 
but basically these studies demonstrated that the hormones 
required for duct growth are estrogen, progesterone and adrenal 
corticoid. When progesterone and prolactin are added to this 
combination full lobulo-a1veolar growth is stimulated. In 
subsequent studies, Talwalker and Meites (1961, 1964) demonstrated 
that frequent large doses of prolactin and growth hormone could 
induce lobulo-alveolar development in the triply operated rat. 
This observation did not imply that the ovarian hormones are of 
no importance in normal mammary growth, but that the pituitary 
hormones must be regarded as the more essential since the ovarian 
hormones in the absence of pituitary hormones have little or no 
mammogenic activity. 
Estrogen and progesterone act synergistically with prolactin 
in stimulating DNA synthesis in rat mammary epithelium. The 
synergistic effects between prolactin and estrogen are exerted 
primarily on the ductal epithelium, whereas the effects of 
progesterone and prolactin arc seen in both ductal and alveolar 
structures (Stoudemire et al., 1975). 
Hypophysectomy does not result in a simple deficiency of 
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only one hormone, and the chronic absence of the anterior 
pituitary leads to extreme metabolic changes in many if not most 
body tissues. In addition to removing the trophic hormones which 
stimulate the ovaries, thyroid and adrenals, hypophysectomy 
retards body growth and homeostasis (Jacobsohn, 1961). The 
mammary glands of intact animals that are starved do not respond 
to ovarian hormones (Enqel, 1954). So, the consequences of 
hypophysectomy may be due in part to reduced food intake. 
Small doses of insulin, if given together with ovarian 
hormones, can induce some development of the mammary ducts in 
hvpophysectomized rats. it is thought that insulin corrects 
some of the metabolic deficiencies which result from pituitary 
ablation (Ahrens and Jacobsohn. 1956). However, it has not 
been demonstrated that insulin alone can elicit mammary growth 
in either intact or hypophysectomized animals. 
The 11-oxygenated corticoids exert no mammogenic effect on 
the ovariectomized mouse and they block the duct-developing 
effects of estrogen. Conversely, 11-desoxycorticosterone synergizes 
the duct-developing action of estrogen in the ovariectomized mouse 
(Flux, 1954). ACTH has no mammogenic effect in intact mice 
(Flux and Munford, 1957), while hydrocortisone acetate is mammo­
genic at low doses and without effect at higher doses (Munford. 
1957). 
The effect of corticoids on the rat mammary gland is 
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conditioned by the endocrine state of the animal. Ahrêns and Jacobsohn 
(1957) found that cortisone was unable to induce normal growth 
in the hypophysectomized-ovariectomized rat even with the addition 
of ovarian hormones. In the pituitary intact ovariectomized 
rat cortisone was lactogenic, its mammogenic effect becoming 
apparent only after addition of ovarian hormones. 
The thyroid does not seem to be essential for mammogenesis. 
A certain degree of hypothyroidism enhances alveolar development in 
the rat, but it has an inhibitory effect on mammogenesis in the 
mouse (Fol ley, 1956). Treating rats with propylthiouracil 
stimulates mammary growth (Ben-David et al., I966). Mammogenesis 
can be elicited in the hypophysectomized-adrenalectomized-thyroidec-
tomized rat by giving ovarian hormones, prolactin, growth hormone 
and hydrocortisone without the addition of thyroid hormones (Chen 
et al., 1955) • 
Growth during pregnancy 
th*? of mammarv orowt'n dur t no 
pregnancy have been reviewed by Turner (1939, 1952) and Jacobsohn 
(1961). Basically, the mammary gland comprises an advance duct 
system at the onset of gestation, and continues its growth through­
out pregnancy. This growth is due to increases in cell size 
(Mayer and Klein, 1961), cell number and area (Cowie, 19^9; 
Munford, 1963). 
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Mammary gland DNA increases throughout pregnancy and, in fact, 
into lactation in the rat (Greenbaum and Slater, 1957; Griffith and 
Turner, 1961; Tucker and Reece, I963). This increase in DNA has 
been observed in guinea pigs (Nelson et al., 1962), mice (Brookreson 
and Turner, 1959) and hamsters (Sinha et al., 1970). The increase 
in DNA values applies mostly to the epithelial cells since 
other cells of the fat pad do not proliferate during 
pregnancy. Also, the increase in parenchymal cells is accompanied 
by increased synthesis of collagen around them whereas the 
collagen content in the rest of the fat pad remains constant 
(Harkness and Harkness, 1956; Paape and Sinha, 1971). 
The mammary RNA content of the rat increases throughout 
pregnancy, with the greatest increase being in the second half 
(Tucker and Reece, 1963; Denamur, 1974; Paape and Sinha, 1971). 
The RNA/DNA ratios increase as pregnancy progresses, but usually 
do not exceed unity (Tucker and Reece, 1963; Ferreri and Griffith, 
1969). 
The placenta, which begins to actively maintain pregnancy 
about day 11 (Amoroso and Porter, 1966), seems to contribute to 
mammary growth in the rat since ovariectomy on day 12 has no effect 
on gestational mammary growth (Selye et al., 1933). Normal gestational 
mammary growth has been observed in mice subjected to ovariectomy^ 
fetus removal, or hypophysectomy on day 12 if the placentae are 
retained (Newton and Lits, 1933; Newton and Beck, 1939; Nagasawa 
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and Nandi, 1971)• 
Hormonal studies of gestational growth 
Hormones in jec ted in to  pregnant  ra ts  can modi fy  the growth o f  
the i r  mammary g lands,  e i ther  because subopt imal  amounts  o f  the 
hormones are  present  o r  because the endogenous hormones cannot  
a t ta in  the i r  fu l l  potent ia l  (Cer ian i ,  1974) .  Thyrox ine in jec t ions 
throughout  pregnancy increase DNA va lues by  25 percent  (Gr i f f i th  
and Turner ,  1961). In jec t ions o f  2 mg/day o f  growth hormone f rom 
day 3~19 of  pregnancy increased DNA va lues by  37 percent .  The 
add i t ion  o f  insu l in  to  th is  t reatment  increases RNA va lues even 
more (Moon,  1965) .  Pro lac t in  in jec t ions in to  pregnant  rabb i ts  
fo r  5 days increase DNA content  to  va lues comparab le  to  the normal  
va lues o f  lac ta t ion .  
Growth during lactation 
Mammary gland proliferation continues through the secretory 
phases of lactogenesis and lactation. Increases in cell numbers 
(Munford, 1963), mitotic activity (Traurig, 1967) and DNA values 
in rats and mice (Lewin, 1957; Greenbaum and Slater, 1957; 
Griffith and Turner, 1961) have been observed. DNA content 
increases approximately 25 percent between the end of pregnancy 
and the 3rd day of lactoticn. This increase in DNA content 
continues and levels off after mid-lactation (Tucker and Reece, 
1963; Griffith and Turner, 1961; Greenbaum and Slater, 1957). 
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This mammary growth occurs at the expense of fat pads which 
diminish appreciably during lactation. 
The maintenance of mammary gland size does not require the 
presence of the ovaries (Griffith and Turner, 1962), nor does 
ovariectomy on the 2nd day of lactation affect the increase in 
mammary gland DNA which accompanies lactation (Griffith and 
Turner, 1961; Tucker and Reece, 1963). 
Pituitary hormones seem to be responsible for promoting 
postpartum mammary gland growth. Hypophysectomy prevents postpartum 
mammary growth. Exogenous prolactin stimulates mammary gland DNA 
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synthesis and will increase P incorporation rates to levels near 
those of pituitary-intact lactating rats (Baldwin and Martin, i 9 6 0 ) .  
Summary of mammary growth 
in the triply operated rat, the ovarian and adrenal steroids 
are only mammogenic in the presence of anterior pituitary hormones. 
The minimal hormonal requirements for duct growth are estrogen, 
cdrsr.al stsrcids and growth hormone. addirion of progesterone 
and prolactin induce lobulo-alveolar growth. it is likely that 
during pregnancy hormones secreted by the placenta are also 
important in mammogenesis. The situation appears to be similar 
in mice despite small variations in mammogenic responses. 
The hormonal control of mammary development in rats (Lyons et al., 
1958) and mice (Nandi, 1959; Nandi and Bern, 1961) are summarized 
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in Fi gure 1. 
Atrophic gland 
E + GH + C 
\!/ 
Duct growth 
E + Prog + PL + GH + C 
E + Prog + C + PL or GH (mice) 
Lcbulo-alveolar growth 
PL + C 
\l/ 
Mi Ik secretion 
\l/ 
Figure 1. The hormonal control of mammary development in rats 
and mice. E = estrogen; Prog = progesterone; GH = 
growth hormone; PL = prolactin; C = corticosteroids. 
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The Hormonal Control of Lactogenesis 
The control of lactation is usually considered in relation to 
two phases: (l) lactogenesis, the initiation of milk secretion, and 
(2) galactopoiesis, the maintenance of an established lactation, 
in lactogenesis some signal of the impending act of parturition 
must be conveyed to the mammary glands so that the biochemical 
apparatus involved in synthesizing and secreting milk may rapidly 
be activated. In galactopoiesis signals generated by the off­
spring must in some way regulate the activity of the glands to 
produce milk sufficient to satisfy their needs (Mepham, 1976). 
Lactogenes i s 
Lactogenesis involves the transformation of the mammary gland 
from a nonsecretory to a secretory state, and the copious flow of 
milk which follows parturition. The epithelial cells of the 
alveoli of mammary glands from rats pregnant 12-19 days have a 
relatively uniform appearance. They are cuboidal to columnar in 
shape and contain many fat droplets. On the 20th day of pregnancy 
the alveoli are distended with secretion, and 9 to 10 hours 
before parturition alveolar distention is still greater and the 
amount of fat in the lumina has increased (Jefters, 1935). 
LacLase (Shinde et al., ,962; Kuhn, 1368) and a-lactalbumin 
(Kuhn, 1968) appear in the mammary gland of the rat between 
days 19 and 20 of pregnancy. RNA synthesis, measured by the 
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incorporation of C-glycine and C-orotic acid for 2h hours, 
increases significantly between day 18 of pregnancy and the day 
following parturition (Wang and Greenbaum, 1962). RNA synthesis 
seems to be necessary for milk secretion since actinomycin-D 
inhibits casein synthesis in overiectomized pregnant rats (Lui 
and Davis, 1967). Cytoplasmic glucocorticoid receptors within the 
mammary epithelium increase significantly by day 16 of pregnancy 
in mice (Chomczynski and Zwierzchowski, 1976). 
DNA increases during late pregnancy and early lactation 
accompanied by rapid increases in more than 30 enzymes. This 
suggests that secretory cell development during lactogenesis 
is a general process involving the synthesis of a large number 
of different proteins (Baldwin, 1969). 
Ovariectomy performed in the rat during mid-pregnancy induces 
the secretory phenomena (Shinde et al., 1965). A significant 
increase in mammary RNA occurs 8-16 hours after surgery on day 15 
(Liu and Davis, 1967). Adrenalectomy (Davis and Liu, 1969) or 
injection of progesterone (Wickerman and Davis, 1968) inhibit the 
nucleic acid and secretory changes caused by ovariectomy. injec­
tions of progesterone during late pregnancy in rats block the 
induction of, a-I acta 1bumin (Turkington and Hill, 1969), lactase 
(Kuhn, 1969) and the histological appearance of milk (Herrenkohl, 
1971). 
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In vitro studies 
The hormonal events that prevail at and immediately prior to 
parturition with respect to cell structure have been studied 
methodically by some investigators using in vitro organ culture 
techniques. This work was reviewed by Topper and Green (1971), 
Turkington et al. (1973), and Topper and Oka (1974). 
The great majority of alveolar cells present in the mammary 
glands of the mouse at mid-pregnancy are nonsecretory (Mills and 
Topper, 1970). They have a paucity of rough endoplasmic 
reticulum and primitive Golgi apparatus. After several days of 
culture in the presence of insulin, hydrocortisone and prolactin 
most of the alveolar cells present in the expiants appear to be 
secretory (Mills and Topper, 1970). The sequence by which the 
hormones induce this transformation has been elucidated. insulin 
promotes the formation of a pair of daughter cells, I-eel Is, 
from virtually every alveolar cell. Hydrocortisone, in the 
presence of insulin, promotes the formation of an extensive rough 
endoplasmic reticulum system. These are termed !h-ce!!s wnicn assume 
a secretory appearance and synthesize milk proteins when exposed 
to both insulin and prolactin. 
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Hormonal  Cont ro l  o f  Ga1actopo ies is  
Pro lac t in  
Grueter  (1923) and St r ieker  and Grueter  (1923) were f i rs t  to  
observe that  aqueous ex t rac ts  o f  the anter io r  p i tu i ta ry  would  induce 
lac ta t ion  in  pseudopregnant  rabb i ts .  Subsequent ly ,  an ter io r  
p i tu i ta ry  ex t rac ts  were shown to  induce mi lk  secre t ion  in  pregnant  
ra ts ,  gu inea p igs ,  rabb i ts  and goats .  The exact  ro le  o f  these 
hormones in  lac togenes is  cou ld  not  be determined because death  o f  
the fe tuses a lways preceded lac togenes is  (Ne lson,  1934; Mei tes  and 
Turner ,  1947) .  La ter ,  in  exper iments  u t i l i z ing  in jec t ions o f  
pur i f ied  pro lac t in ,  lac ta t ion  was not  in i t ia ted in  ra ts  (Ta lwalker  
e t  a l . ,  1961), mice (Nandi  and Bern,  1961), or  ewes (De lou is  and 
Denamur ,  1967) al though pregnancy was not  a f fec ted.  Pro lac t in  
did initiate lactation in pregnant rabbits (Meites et al., 1963). 
Hypophysectomy during lactation causes a rapid decline in milk 
yield (Selye et al., 1933). In the rat milk secretion is completely 
suppresses v-nrnin 1-3 days (Cowie. 1357). Xammary cell numbers, 
DNA, RNA and several enzymes essential for milk synthesis are 
reduced following hypophysectomy (Baldwin and Martin, 1968; Jones, 
1967). Cowie (1957) maintained lactation for a few days in 
hypophysectomized rats with injections of 50 lU of prolactin twice 
daily. Better milk yields were obtained, however, when ACTH or 
growth hormone was given concomitantly with 25 IDs of prolactin 
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twice daily. Later studies revealed that the minimum requirements 
for maintaining lactation at a level sufficient to rear litters were 
an adrenal corticoid or ACTH and prolactin (Bintarningsih et al., 
1957, 1958). Lyons et al. (1958) found that the addition of growth 
hormone improved this milk yield, but did not return it to pre-
hypophysectomy levels. 
Crude extracts of the anterior pituitary were shown to be 
lactogenic in hypophysectomized rats also, but purified prolactin 
was not lactogenic unless combined with ACTH (Gomez and Turner, 
1937) or cortisone (Nelson et al., 1943). Using triply operated 
rats (Lyons et al., 1958) and mice (Nandi, 1959; Nandi and Bern, 
1961), prolactin and adrenal glucocorticoids were demonstrated to 
be the minimum requirements for lactation. In some strains of 
mice growth hormone can completely replace prolactin (Nandi and 
Bern, 1961). 
Prolactin secretion occurs at a high rate throughout the 
major part of the 21 day lactation period in the rat (Neill, 1974). 
The maintenance of prolactin secretion during lactation is sustained 
by the frequent application of the suckling stimulus. The suspen­
sion of nursing is accompanied by an increase in pituitary prolactin 
levels (Mettes, Sar and Voogt, 1969) and suckling increases 
plasma prolactin concentrations (Ratner and Meites. 1964). 
Daily injections of prolactin to lactating rats produced 
little, if any, increase in the litter growth rate (Masson, 1947). 
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Déclin (1952) observed that prolactin was not luteotrophic and 
lactogenic at the same time. A definite galactopoietic effect 
was observed in lactating rats receiving daily injections of 1 mg 
of prolactin (Johnson and Meites, 1957). Later, Talwalker et al. 
(i960) found that daily injections of 1 mg of prolactin did 
stimulate litter weight gains of rats during early lactation. 
Doses of 3 mg/day have been found to be stimulatory to milk secre­
tion primarily through increased metabolism rather than increases 
in the size of the mammary gland (Kumaresan et al., 1966)-
Lactational performance in the rabbit is greatly enhanced by 
exogenous prolactin during late lactation (Cowie, 1969). 
Prolactin appears to increase the synthetic rate of all types 
of RNA in a general fashion. This ultimately leads to increases 
in tissue levels of RNA and rates of protein synthesis (Baldwin 
et al., 1969; Baldwin and Martin, 1968). 
Ovarian hormones 
Ovarian hormone admin•strat' O "  n n r i n g  lactation inhibits 
lactational performance. Parkes and Bellerby (1927) showed that 
ovarian extracts depressed litter growth when administered to 
lactating mice. Later, chorionic gonadotropin was found to 
inhibit lactational performance in mice (De Johng, 1933). 
Ovariectomy prevents the inhibitory effects of exogenous 
estrogen (Anselmino and Hoffman, 1936) and chorionic gonadotropin 
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(Edelmann and Gaunt, 1941) on lactational performance. 
The detrimental effects of ovarian hormones on lactation and 
litter growth rate have been confirmed in numerous studies. 
These investigations have been summarized in the reviews of Nelson 
(1936), Turner (1939), Fol ley and Mai press (1948), Cowie (1961) 
and Cowie and Fol ley (1961). 
Both physiological and pharmacological doses of estrogenic 
compounds suppress lactation in intact rats. The degree of inhibi­
tion seems to be related to the amount of hormone administered 
(Barsantini and Masson, 1947; Walker and Matthews, 1949; Ben-David 
et al., 1965; Gala and Reece, 1962). Physiological doses of 
estrogen do not affect lactation in ovariectomized rats, only 
pharmacological doses are effective (Griffith and Turner, 1962). 
Progesterone treatments in the normal ranges do not affect 
lactational performance in rats (Anselmino and Hoffmann, 1936; 
Fol ley, 1942; Walker and Matthews, 1949; Griffith and Turner, 1962; 
Ben-David et a)., 1965). Barsantini and Masson (1947) reported 
a 25 percent depression in litter weights on rats receiving 25 mg 
of progesterone daily for 16 days. 
Fauvet (1941) demonstrated that the inhibition of milk 
secretion was due to the combined effects of estrogen and 
progesterone. This observation was subsequently confirmed 
(Barsantini et al., 1946; Masson, 1948; Walker and Matthews, 1949). 
Depression of milk secretion observed in the intact rat after 
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estrogen treatment is thought to be due to the combined effect of 
the exogenous estrogen and of the progesterone from the resulting 
corpus luteum (Cowie, 1961). 
Estrogen-progesterone treatment inhibits lactational performance 
in both intact and ovariectomized rats. The hormones are effective 
in physiological doses. 
Mammary gland DNA content is not affected by estrogen-
progesterone treatments (Griffith and Turner, 1962; Hodson, 1971). 
A decrease in RNA content was observed by Hodson (1971). 
The mammary glands of estrogen-progesterone treated rats 
contain milk (Griffith and Turner, 1962; Knox and Griffith, 1970; 
Bruce and Ramirez, 1970). Milk was also seen in the stomachs of the 
pups of these dams (Hodson, 1975). Reduced growth of litters of 
estrogen-progesterone treated animals then is not a clear indication 
of an inhibition of milk secretion. 
Wei chert and Kerrigan (1942) theorized that pups of estrogen 
treated rats grow at a reduced rate due to changes in maternal 
behavior rather than failure of the mother's milk supply. However, 
no changes in maternal behavior were observed in dams treated with 
progesterone during pregnancy (Herrenkohl, 1971) or ergocornine 
during lactation (Numan et al., 1972). 
Since lactation is suppressed by doses of estrogen in the range 
which stimulates prolactin release, inadequate amounts of prolactin 
do not seem to explain the inhibition of lactational performance 
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during ovarian hormone treatment. 
Estrogen treatments ranging from .1 ug to 500 ug per day 
increased prolactin production and secretion (Chen and Meites, 1970). 
Kalra et al. (1373) observed increased plasma prolactin levels after 
single doses of estrogen, progesterone or estrogen-progesterone. 
Prolactin was shown to override the inhibitory effects of 
stilbesterol administered during lactation (Noble, 1939). 
An antagonistic relationship between prolactin and estrogen-
progesterone was detected by Meites and Sgouris (1353, 1354). 
Estrogen-progesterone administration blocked the lactogenic effects 
of intraductal prolactin injections in rabbits. If larger 
dosages of prolactin were given, the inhibitory effects of estrogen-
progesterone were overridden. Both estrogen and progesterone 
were required to block the lactogenic effect of prolactin. 
Adrena 1 sterolds 
Lactation can be initiated during gestation in the rat 
(Talwalker et al., 1961), mouse (Mandi and Bern, 1361) and rabbit 
(Meites et al., 1963) with glucocorticoid injections. The 
combination of prolactin and glucocorticoid will induce milk 
secretion similar to normal lactation (Reece, 1939; Meites et al., 
1963*, Friesen, 1966). 
A small increase in mammary gland RNA in response to 
hydrocortisone acetate was observed in pregnant rats (Ferreri and 
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Griffith, 1969). Nevertheless, the increase was not as great 
as the normal increase at parturition. 
Lactation is impaired when the lactating animal is adrenalec-
tomized (Cowie and Tindal, 1958; Anderson and Turner, 1962, 1963). 
Lactation ceases even sooner if the anima! is simultaneously 
ovariectomized and adrenalectomized (Flux, 1955; Anderson and Turner, 
1963). 
Either glucocorticoids or mineralocorticoids will partially 
restore milk secretion, but a combination of the two is most 
effective (Cowie and Tindal, 1953). 
Lactational performance has been increased 12-27 percent 
in lactating rats with injections of optimum doses of corticosterone 
(Hahn and Turner, 1966), Cortisol acetate (Talwalker et al., I960), 
cortisone acetate or ACTH (Johnson and Meites, 1958). Pharmacological 
doses of corticosteroids are inhibitory to lactation (Kowalewski, 
1969). 
Cortisol appears to act specifically by increasing the synthetic 
rate of nonribosomal RîiA (Baldwin et al., 1969)- Thatcher and 
Tucker (1970) found the adrenal corticosterone content to be 
highly correlated with mammary gland nucleic acid content during 
lactation. ACTH and adrenal functions decrease simultaneously 
with decreases in milk synthesis. Glucocorticoid supplementation 
prevents the reduction in milk synthesis strongly suggesting that 
adrenal secretions are rate limiting to milk synthesis during 
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prolonged lactation in the rat. 
When high fat diets are administered in conjunction with 
glucocorticoids, both mammary gland nucleic acid content and 
lactational performance can be maintained at maximum values for 
at least 32 days (Emery et al., 1971). 
Brain amines and prolacti n 
in rats systemic injection of a wide variety of amines and 
other substances thought to be involved in neural transmission 
including adrenaline, noradrenaline, acetylcholine and serotonin 
can elevate prolactin secretion (Mittler and Meites, 1967; 
Kamberi et al., 1971a). Monoamine oxidase and catechol-0-methyi 
transferase inhibitors, which interfere with normal amine 
inactivat ion, both depress serum prolactin levels while at the same 
time elevate hypothalamic PIF content. Conversely, drugs which 
in some way interfere with amine function including reserpine, 
chlorpromazine, fluphenazine and perphenazine all increase plasma 
prolactin levels and reduce hypotnaiamic P i F content (Ben-David et 
al., 1971; Meites et al., 1972; Sulman and Winnik, 1956). 
Serotonin and melatonin injected into the 3rd ventricle in 
rats stimulate prolactin and inhibit FSH secretion (Kamberi et al., 
1971b). Systemic injections of the serotonin precursors tryptophan 
and 5-hydroxytryptophan both elevate serum prolactin levels 
significantly (Lu and Meites, 1971; Meites and Clemens, 1972). 
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MATERIALS AND METHODS 
Treatment of Animals 
Six female rats weighing at least 180 grams and 1 mature 
male of the Sprague-Dawley strain were placed in large cages for 
breeding. These animals remained together until the females were 
visibly pregnant. Animals in treatment groups L, EPL, and EPLF 
were purchased pregnant from ARS/Sprague-Dawley of Madison, 
V/i scons i n. 
Pregnant animals were caged individually and provided with 
shredded newspaper for nest material. A standard diet (Teklad) 
and water were provided ad libitum throughout the investigation. 
A light cycle of 14:10 with lights on from 8:00 A.M. to 10:00 P.M. 
and temperature of 25 ± 3°C were the standard animal room conditions. 
The day following parturition was designated day 1 of 
lactation. On day 1 litter sizes were adjusted to 8 pups; dams 
were assigned to experimental groups; those in group 0 were 
ovariectomized, and hormonal treatments were begun. 
Subcutaneous injections of the respective hormone(s) were 
given each morning through day 10 of lactation. Litters were 
weighed also at this time. Litter size was readjusted to 6 pups 
on day 4. Dead or injured pups were replaced with pups of equal 
weight. 
All animals were sacrificed by decapitation on the morning 
27  
of day 11. The abdominal-inguinal mammary glands were excised, 
minced and defatted. Adrenals and pituitaries were removed and 
we i ghed. 
Treatment groups and symbols used to identify them are listed 
i n Table 1. 
Hormone Preparation 
Estrogen-Progesterone (EP) 
A stock estrogen solution was prepared by combining 0.1 gm 
of estradiol benzoate, 5 ml of benzyl alcohol and 95 ml of 
Mazola corn oil. 
The estrogen-progesterone solution was prepared by combining 
3 grams of progesterone, 1 ml of stock estrogen, 5 ml of benzyl 
alcohol and enough Mazola corn oil to make 100 ml of solution. 
This solution was heated in a water bath to 35°C and continuously 
stirred with a magnetic stirrer for several hours. The quantity 
injected was 1 yg E + 3 mg P in 0.1 ml corn oil. 
Prolactin 
Ovine prolactin (N1H-P-S12) was dissolved in less than 5 ml 
of .9% saline adjusted to pH 8.0-8.5 with NaOH, then filled to 
volume (5 ml). The required quantity was injected in 0.1 ml of 
alkaline saline. 
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Table 1. Treatment groups 
Group Symbol 
it i n 
Group 
Hormonal Treatment 
C 11 None 
F 11 250 yg Hydrocortisone Acetate (F) 
EP 12 1 y g  Estrogen (E) + 3 mg Progesterone (P) 
EPF 11 1  y g  E + 3  mg P + 250 yg F 
EPF-1 1 1 1 yg E + 3 mg P + 1 2 5  yg F 
EPF-2 1 1 1 y g  E + 3 mg P + 6 2 . 5  y g  F 
L 10 1 mg Prolactin (L) 
EPL 10 1 yg E + 3 mg P + 1 mg L 
EPLF 10 1 y g  E + 3 m g P + l m g L +  2 5 0  y g  F  
EPL-IF 7 1 yg E + 3 fng P + . 25 mg L + 250 yg F 
0 (ovariectomized) 8 1 yg E + 3 m g P + I m g L +  2 5 0  y g  F  
5-HTP 12 3 mg 5 - hydroxytryptophan 
Hydrocort i sone acetate 
Hydrocortisone was suspended in a carrier solution consisting 
of 100 ml of saline, 0.9 ml of benzyl alcohol and 1 drop of 
Tween 80 per 5 ml of saline. The suspension was kept in a 
storage bottle in the refrigerator. The solution was shaken 
before each injection to maintain the suspension. The required 
amount of hormone was given in 0.1 ml of solution. 
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5-Hydroxy tryptophan 
L- 5 -hydroxytryptophan (ICN Pharmaceuticals) was dissolved in 
slightly alkaline saline to which 0.5 N HCl was added a drop at 
a time to bring the pH to 6.5-7.0. The injected amount was 1.5 mg 
per 0.1 ml twice daily. 
Mammary Gland Nucleic Acid Analysis 
Preparat i on of dried fat free t i ssue (DFFT) 
Immediately after removal, the 6 abdominal-inguinal mammary 
glands were defatted in approximately 50 ml of chloroform-methanol 
(2:1, V/V) for 2 12-hour periods, and in ether for 2 subsequent 
12-hour periods. Vials were continuously agitated during the 
extraction periods. After the final solvent was decanted, the 
tissues were allowed to air dry under a fume hood. The DFFT was 
weighed and ground to a fine powder in a Wiley mill with a number 
20 sieve. 
rJuc Ieic aci d extraction 
Nucleic acid was extracted from the DFFT by the method of 
Schneider (19^5) as modified by Ferreri (1971). A 25 mg sample of 
DFFT was suspended in 5 ml of 5% trichloroacetic acetic acid (TCA) 
in a thick walled 15 ml volumetric centrifuge tube. This was 
allowed to stand at room temperature until the DFFT became 
saturated and settled to the bottom of the tubes with gentle tapping. 
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Samples were then covered with glass marbles to prevent 
evaporation and placed in a hot water bath (90-95°C) for 15 minutes 
and then placed in a cold water bath. Samples were centrifuged for 
30 minutes, and the supernatant decanted into 12 ml volumetric 
centrifuge tubes. 
A second extraction in 5 ml of hot TCA was made on the 
centrifugate, and the supernatant added to that recovered from the 
first extraction. The total volume was brought up to 10 ml with 
cold S% TCA, transferred to screw capped glass tubes and stored 
at 4°C. 
Color imetr ic  determinat ion o f  DNA content  
DNA concentrations were measured by the diphenyl amine reaction 
(Burton, 1956; Ferreri, 1971). One ml of the nucleic acid extract 
was combined with 1 ml of 1 N perchloric acid and 4 ml of 
diphenylamine reagent. Diphenylamine reagent was prepared 
immediately before use, and consisted of 1.5 g of reagent grade 
d : phcr.y'.ami ne !n 100 ml of «.R. acetic acid. 1.5 ml of concentrated 
s u l f u r i c  a c i d  a n d  0 . 5  m l  o f  a c e t a l d e h y d e  ( 1 6  m g / m l ) .  
A blank was prepared with 1 ml of 5% TCA, 4 ml of diphenylamine 
reagent and 1 ml of perchloric acid. Samples were kept for 16-20 
hours at room temperature, and absorbance was measured against the 
blank at 600 my. 
The concentrat ion o f  DNA in  the sample was ca lcu la ted f rom a 
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least squares estimate of the slope and Y intercept of the standard 
curve, plotting absorbance vs. concentration. 
RNA concentration was determined by the orcinol reaction 
outlined by Schneider (1957). 
Half a milliliter of nucleic acid extract, DNA or RNA standard 
was combined with 2.5 ml of orcinol reagent and 2 ml of 5% TCA. 
Orcinol reagent consisted of 0.5 g of FeCl^ in 100 ml of concen­
trated HCl and 1 g of orcinol prepared immediately prior to use. 
Samples were heated for 20 minutes in hot water (90-95°C) . 
A blank was prepared with 2.5 ml TCA and 2.5 ml of orcinol 
reagent. Absorbance was measured against the blank at 660 my. 
Both DNA and RNA standards were used in this procedure so that 
corrections for absorbance due to DNA could be subtracted from the 
total optical density. Remaining optical density was due to RNA, 
and the concentration was calculated from a least squares estimate 
of the slope and Y intercept of the standard curve, plotting 
corrected absorbance vs. concentration. 
Preparation of nucleic acid standards 
Stock solutions of hydrolyzed DNA and RNA were prepared by 
dissolving 100 mg of nucleic acid in 80 ml of hot (90°C) 5% 
TCA. This temperature "was maintained for 15 minutes while the 
solution was constantly stirred with a magnetic stirrer. The 
samples were then allowed to cool and total volume brought up to 
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TOO ml with 5% TCA. From these, dilutions were made for determina­
tion of standard curves. 
Statistical Analysis 
Separate analyses of variance (ANOVA) were conducted for all 
variables. The total variation of treatments was subdivided into 
orthogonal comparisons. A split-plot analysis of variance was used 




Final Body and Organ Weights 
Body weights (Table 2) 
The average body weights of rats used in these experiments 
ranged from 256.4 grams for EPLF to 365-36 grams for EPF-2. A11 
groups except C, L and 0 gained weight during the treatment 
period. C, L and 0 animals lost an average of 12.9, 0.4 and 9-85 
grams, respectively. 
Dried fat free tissue (DFFT) weights 
Hormonal treatments affected DFFT weights (p < .0001). The 
difference between the DFFT weights of EP vs. EPF-2 approached 
significance (p < .05). However, there were no significant 
differences in DFFT weights between the pooled mean of EP and EPF-2 
and EPF-1 or EPF. C vs. F and EPL vs. EPLF exhibited similar 
weights. DFFT of 5HTP animals was significantly greater (p < .05) 
than that of L animals. 
Pi tui tary weights 
Pituitary weights were similar in all groups and did not differ 
significantly in any of the planned comparisons. When the mean 
pituitary weights of groups administered prolactin were pooled and 
compared with groups which did not receive prolactin, the groups 
without prolactin exhibited significantly higher (p < .0001) 
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Table 2. Effect of hormonal treatments on final body weight, 
mammary gland dried fat free tissue, pituitary and 
adrenal weights 
Group B.W. (gm) DFFT (gm) Pituitary (mg) Adrenals (mg) 
c 260.72 
±39.60 
1 . 0 5 3  
±.142 





±31. 6 9  
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The adrenals of animals receiving 125 and 62.5 pg of hydrocorti­
sone were significantly larger (p < .01) than those of animals 
administered 250 yg of hydrocortisone. The animals with the 
largest adrenals were EPL-IF (115.56 mg) and EPF-1 (92.69 mg), 
both of which were markedly different (p < .001) from controls 
(62.52 mg). 
Mammary Gland DNA 
DNA content - ]ig_ DNA/mg DFFT (Tables 3 and 4) 
The average yg DNA/mg DFFT of EP animals was 34.74. Graded 
levels of hydrocortisone, 250 yg, 125 yg or 62.5 yg, administered 
simultaneously with estrogen-progesterone did not significantly 
affect DiNA content. The presence of hydrocortisone did slightly 
reduce the DNA values. The pooled mean of groups EP, EPF, EPF-1 
anri FPF-2 wa? significantly higher vp < .001; than the average 
yg DNA/mg DFFT value of control animals. 
DNA values of F (23-35) vs. C (25-38), L (27-95) vs- 5HTP 
(26.19) and EPL (28.94) vs. EPLF (27-19) did not differ significantly. 
Animals in groups given estrogen-progesterone alone or in combina­
tion with hydrocortisone had higher (p < .0001) yg DNA/mg DFFT 
values than animals which received prolactin alone or in combination 
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Table 3. Effect of hormonal treatments on mammary gland DNA 
content 
Group yg DNA/mg DFFT Total DNA DNA/100 g B.W. 
c 25.38 
± 2 . 3 6  
26.57 
±3.14 




2 7 . 8 0  
± 3 . 0 2  
9.76 
±1. 8 2  
EP 34.78 
± 5 . 2 1  
30.90 
±7.58 
1 1 . 2 6  
±2.46 
EPF 32.41 
± 5 . 2 6  
34.42 
± 6 . 3 7  
12.90 
±2.54 
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1 1 . 9 0  
± 1 . 5 6  
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2 6 . 8 0  
±4.25 
1 0 . 3 2  
±1.42 
EPLF 27.17 
+ 11 j 
2 8 . 9 6  
±5 • 05 
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n.88 
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0 27.62 
± 2 . 7 8 5  
29.35 
±3.57 
1 0 . 8 3  
±1.42 




— J J 
10.20 
J- ]. 32 
Table 4. Analysis of variance of DNA concentration 
Degrees Sum of Mean Level of 
Source F reedom Squares Squares F Significance 
T reatments 9 1394.4 154 9 .79 .0001 
EP vs EPF-2 I  36.3 36.3 2 .3  Not s igni ficant 
EP 4- EPF- 2 vs EPF-1 1 27.1 27.1 1 .7 Not significant 
EP H- EPF-2 vs EPF 1 6.0 6.0 < 1 Not significant 
C vs F 1 22.7 22.7 1 .4 Not significant 
L vs 5HTP 1 24.9 24.9 1 6 Not significant 
EPL vs EPLF 1 15.7 15.7 < 1 Not significant 
EP, EPF, EPF-], EPF-2 vs 















with estrogen-progesterone, F alone and controls. 
Total DNA and pg DNA per 100 g body weight (Table 3- Figs. 2 and 3) 
The total DNA of EP (30.90) and EPF-2 (32.33) were not 
significantly different. The total DNA of EPF-1 was significantly 
different (p < .01) from EP and EPF-2. The combined mean of EP, 
EPF-2 and EPF-1 was similar to that of EPF. 
No statistically significant differences were observed 
between C (26.57) and F (27.80), L (31-72) and 5HTP (35.09) or 
EPL (26.So) and EPLF (28.90). The average total DNA of animals 
in groups EP, EPF, EPF -2 ,  and EPF -2  was significantly (p < .001)  
higher than animals which received prolactin alone or in combination 
with estrogen-progesterone, F alone and controls. 
There were no significant differences in the DNA/100 g body 
weight values between any groups. The lowest value, 9-76, was found 
in group F but it was not markedly different from controls. 
Mammary Gland RNA 
RNA per mg DFFT and mg RNA per 100 g body weight (Tables 5 and 6. 
Figs, k and 5) 
The overall effects of hormonal treatments on mammary gland RNA 
content were highly significant (p < .0001). When the treatment 
effects were partitioned out into single degree of freedom compari­

















O Li U 
•  • • I S B  I I I  I  I  I  
I  I  I  1 1  I  I  I  I  1 1  I  LLUJili 
C EP EPF EPF-1 EPF-2 
uroup 
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Table 5- Effect of hormonal treatment on mammary gland RNA 
content 
Group ug RNA/mg DFFT Total RNA RNA/100 g B.W. RNA/DNA 
C 70.73 74.28 29.14 2 . 8 0  
±6.60 ±10.61 ± 6 . 5 2  ±0.34 
F 89.36 106.97 37.44 3.86 
±14.33 ±19.38 ± 8 . 2 8  ±0.66 
EP 54.32 49.74 18.21 1.61 
±13.13 ±20.14 ±1.11 ± 0 . 5 0  
EPF 68.00 72.42 27.21 2 . 1 5  
±6.60 ±10.11 ±4.88 ±0.41 
EPF-1 64.65 102.19 28.14 2.05 
±12.71 ±27.21 ±1.11 ±0.44 
EPF-2 55.42 60.13 18.69 1.76 
±7.32 ±18.55 ±5.92 ±0.42 
L 74.30 84.46 31.71 2.67 
±7.62 ± 8 .58 ±4.17 ± 0 . 2 5  
EPL 77.65 71.75 27.47 2.71 
±14.08 ±13.88 ± 4 . 7 2  ±0.62 
EPLF 95.53 109.79 39.67 3.52 
±6.47 ±10.97 ±3 = 34 ±0.26 
EPL-IF 77.43 124.05 3 6 .36 3.11 
±2.i 56 ±14.802 ±3.40! ±0.314 
0 97.09 105.77 37.26 3.44 
±3.37 ± 1 2 . 7 2  ±4.37 ±0.75 
5-HTP 81.71 112.45 3 2 . 5 0  3.21 
±10.19 ±31.42 ±7.59 ±0.76 









S i gn i f i cance 
T reatments 9 18148 2016 18.58 .0001 
EP vs EPF-2 1 7 7 < 1 Not significant 
EP + EPF-2 vs EPF-1 I 926 926 8.53 .005 
EP + EPF-2 vs EPF 1 936 936 8.63 .005 
C vs F 1 1911 19)1 1 7 . 6  .005 
L vs 5HTP 1 385 385 3.55 .05 
EPL vs EPLF 1 1599 1599 14.7 .005 
EP, EPF, EPF-1, EPF-2 vs 
C, F, L, EPL, EPL-1, EPLF 
1 11552 11552 1 0 6.4 . 0 0 5  
Rema i nder 2 832 416 
Error 100 1 0 8 5 0  108.5 
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Therefore the means of these two groups were pooled for further 
comparisons. EP + EPF-2 were significantly lower (p < .005) than 
EPF-1 (64.65) and EPF (68.00). 
All RNA parameters of F treated animals were significantly 
higher (p < .005) than corresponding control parameters. Estrogen-
progesterone treatments suppressed mammary gland RNA. Mean of any 
RNA parameter for EP, EPF, EPF-1 and EPF-2 was significantly less 
(p < .001) than the mean RNA value for controls. 
Prolactin in combination with estrogen-progesterone slightly 
elevated yg RNA/mg DFFT values (77.65) when compared to prolactin 
alone animals (L, 74.30). This increase was not statistically 
significant. When F was added to the estrogen-progesterone-prolactin 
(EPLF) complex, all RNA parameters were significantly (p < .005) 
i ncreased. 
5HTP animals exhibited higher (p < .05) yg RNA/mg DFFT values 
than group L animals. RNA/100 g body weight values of the two 
groups were similar. 
RNA to DMA ratio (Table 5- Figs. 6 and 7) 
The RNA to DNA ratio in the mammary glands of EP (1.61) and 
EPF-2 (1.76) animals did not differ significantly. They were 
lower (p < .05) than EPF (2.15) and EPF-1 (2.05). All combinations 
of estrogen-progesterone and hydrocortisone, EP, EPF, EPF-1 and 
EPF-2, were significantly (p < .001) lower than controls (2.80). 
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ratio (p < .0001) above controls (C, 2.80). In the case of the 
animals receiving prolactin in combination with EP, RNA:DNA was 
increased (2.71) to near controls. When F was added to this 
combination, the RNA:DNA ratio (3.52) exceeded (p < .005) controls. 
5HTP animals showed an increased (p < .01) RNA:DNA 
ratio (3.21) when compared to group L animals (2.67). 
Li t ter  Weight  Gains 
Litter growth curves (Tables 7 and 8. Figures 8, 9, 10 and 11) 
Hormonal treatment of the lactating dams had profound effects 
on litter weight gains (p < .0001). Litter weights of EPF-2 
animals were suppressed equivalent to EP litters. Pups of EPF-2 
animals were slightly larger than EP + EPF-2, with the difference 
approaching significance (p < .05). EPF litters were significantly 
larger (p < .01) than either EP, EPF-1 or EPF-2. When the average 
litter gains of EP, EPF, EPF-1 and EPF-2 were compared to controls, 
they were smaller (p < .05). 
Two hundred-fifty yg of hydrocortisone had a positive effect 
on litter weights. Litters of F treated animals were significantly 
(p < .05) larger than controls. Litters of L treated animals were 
larger (p < .05) than 5HTP litters. Litters of EPL and EPLF were 
not significantly different when treatment only was considered. 
Litters of 0 animals were the largest of all experimental 
groups. They were significantly larger than controls, F and 











Treatment (TRT) 9 1528.0 169.8 5.98 .0001 
EP vs EPF-2 1 70.3 70.3 2.47 Not signifi cant 
EP + EPF-?, vs EPF-1 1 86.8 86.8 3.06 . 10 
EP + EPF-;: + EPF- ) vs E P F  1 367. G 367.8 12.95 .01 
C vs F 1 138.3 138.3 4.87 .05 
L vs 5HTP 1 143.4 143.4 5.05 .05 
EPL vs EPLF 1 2 . 1  2.7 0. 10 Not significant 
Rema i nder 3 716.8 272.3 
Total Rats 100 2839.6 20.4 
SPLIT-PLOT 
T i me 10 12851.2 1285.1 827.2 .0001 
Time X TRT 90 
Linear X TRT 9 
EP vs EPF-2 X TRT 
EP + EPF-;? vs EPF-1 X TRT 
EP + EPF-2 + EPF-2 vs EPF 
X TRT 
C vs F X TRT 
L. vs 5HTP X TRT 
EPL vs EPI.F X TRT 
Remainder vs TRT 3 
Higher orders X TRT 8l 
E r r o r  1000 
1306.4 
1 2 0 0 . 0  
2.9 








14 .5 9.34 . 0 0 0 1  
133 .3 8 9 . 2 6  . 0 0 0 1  
2 
.9 1. 8 7  flot significant 
125 . 2  8 0 . 7 7  . 0 0 0 1  
171. 3 1 1 0 . 5 2  . 0 0 0 1  
14, 
.7 9.8 .01 
2 1 6 .  3 139.55 . 0 0 0 1  
27. , 0  17.42 .005 
214. 2  138.19 . 0 0 0 1  
1. 3 0.84 Not significant 
1.55 
Table 8. Average daily pup weights (gm) 
Group 1 2  3 4 
D( 
5 
C r. 73 6 .  49 7 2 0  8 58 9 . 6 0  
± 0  49 ± 0 .  53 ± 0 .  56 ±1 70 ±1.85 
F () 84 7. 6 2  8 24 9 36 10.81 
± 0 .  58 ±0. 74 ±0.94 ±0.5 6  ±0.67 
EP I) 79 7. 48 8 2 5  9 03 9.77 
± 0 .  46 ±0. 53 ± 0 .  5 4  ± 0  78 ±1 . 12 
EPF 6 .  57 7 .  06 8 30 9 35 10.58 
± 0  79 ±0. 92 ±0 62 ±0 75 ±0.92 
EPF-I 6 .  04 6. 73 7 50 8 4o 9.37 
± 0  65 ±0. 68 ±0 59 ± 0  55 ±0.68 
EPF-2 5 63 6 22 6 54 8 21 8.74 
±1 16 ±1. 29 ±1 64 ±1 55 ±1.87 
L 5.85 6.49 7 46 9 21 10.62 
±0.89 ±1 14 ± 1 14 ±1 41 ±2.22 
EPL 6 17 6. 81 7 44 9 27 10.15 
± 0 .  60 ±0. 84 ±0.98 ±0. 59 ±0.67 
EPLF 5 98 6. 71 7 35 8 35 9.55 
± 0  59 ± 0 .  61 ± 0  91 ±1 00 ±0.93 
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± 0 . 6 1  
5.84 6.77 
± 0 . 5 5  ± 0 . 5 8  
8 . 2 7  8 . 6 1  
± 0 . 9 4  ± 0 . 5 7  
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L (p < .001 and .05, respectively). 
When the effects of treatments were analyzed over time, the 
differences in effects became even more apparent (Table 8, 
split-plot ANOVA). There was a linear relationship between treat­
ment and time in 90 percent of the growth curves. EP and EPF-2 
were still essentially the same. Significant differences (p < .0001) 
between the growth curves of EP + EPF-2 and EPF-1 became evident 
in this analysis. The pooled slope of EP, EPF-2 and EPF-1 growth 
curves was much less (p < .0001) than that of EPF. The slope of the 
growth curve of control animals was larger (p < .001) than the 
mean of the combined slopes of EP, EPF, EPF-1 and EPF-2. 
The differences between C, L and F were not as extreme as the 
EP groups, but F and L did exhibit greater (p < .01) slopes than 
C. There was no difference between slopes of F and L. The 
presence of F enhanced the growth rate of EPLF litters producing 
a significantly (p < .005) larger slope than EPL litters. This 
effect could not be seen when treatment effects were analyzed 
ignoring time. When combined with hydrocortisone, smaller doses 
of prolactin (EPL-IF) overcame the suppressive effects of EP on 
1itter growth. 
5HTP treatments diminished litter growth rates. The slope of 




The principal difference between the complex of hormones required 
for full mammary gland development and those required for lactation 
appears to be the ovarian steroids (Lyons et al., 1958). This has 
led to the view that the estrogen-progesterone equilibrium during 
pregnancy inhibits the initiation of lactation. They inhibit 
prolactin secretion and its effects on mammary cells (Meites, 1966). 
At parturition the fall in plasma progesterone, coupled with the 
temporary maintenance of high levels of estrogen, renders the 
mammary gland receptive to the lactogenic actions of prolactin and 
glucocort i coids. 
The biological actions of glucocorticoids may be minimized during 
pregnancy due to increased binding to corticoid binding globulin (CBG). 
Gala and Viestphal (1965) observed a marked fall in CBG values and a 
coincidental rise in free corticosteroids during late pregnancy and 
early lactation. Exogenous hydrocortisone during late pregnancy 
increased RXA content (Ferrer: and Griffith, 1969) and induced 
mammary secretions (Talwalker et al., 1961). This suggests that the 
availability of active glucocorticoids could be the limiting factor 
for lactogenesis during pregnancy. 
The inhibitory effects of estrogen-progesterone on lactation 
have been previously established (Cowie, 1961; Griffith and Turner, 
1962, Hodson, 1975). The results of this investigation agree with 
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these earlier studies. Estrogen-progesterone treatments depressed 
RUA content, RNA/DNA ratio and litter weight gains, all of which 
are estimates of mammary cell secretory activity. Conversely, 
yg DNA/mg DFFT and total DNA values of these animals were increased 
significantly above controls. 
The ability of hydrocortisone to overcome the suppressive 
effects of estrogen-progesterone on lactation is dependent on the 
quantity administered. The lowest quantity used in this study, 
62.5 yg, was unable to override the estrogen-progesterone effects. 
In fact, litter growth was further depressed and nucleic acid 
parameters unaffected. The adrenals of these animals were significant­
ly smaller than estrogen-progesterone animals probably due to 
decreased endogenous adrenal steroid secretion. This low level 
of hydrocortisone could possibly have synergized with estrogen-
progesterone in their mammogenic actions or could have been converted 
to progesterone. The latter would explain the increased depression 
of litter weight by this quantity of hydrocortisone. 
Ahrens and Jacobsohn (1957) found normal mammary gland growth 
to be inhibited or impeded by estrogen-progesterone plus 1 mg of 
cortisone when the metabolic actions of cortisone could not be 
counteracted efficiently. The animals in the estrogen-progesterone 
plus 62.5 hydrocorti5one group all gained weight during the 
experimental period; therefore, increased metabolic activity then 
would not seem to explain the detrimental effects of this hormonal 
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combination on litter growth. 
Estrogen-progesterone plus 125 yg hydrocortisone treated 
animals exhibited significant increases in RNA content and RNA/DNA 
ratio. The RNA/DNA ratio of this group was significantly less than 
controls and higher than estrogen-progesterone alone. The RNA/DNA 
ratio of this group was equal to ratios reported by Tucker and 
Reece (1963) for normal lactating rats. This group exhibited the 
highest total DNA and mg DNA/100 g body weight values of all experi­
mental animals. One hundred twenty-five yg of hydrocortisone then 
appears to be optimum for maximum mammogenesis. This action could 
be through synergism with estrogen-progesterone or through mimicry 
of their effects. 
Litter weights of animals receiving 250 yg of hydrocortisone 
plus estrogen-progesterone were equal to controls. RNA content and 
RNA/DNA ratio of these animals were in the range of normal lactating 
animals in this and other studies (Griffith and Turner, 1962; 
Tucker and Reece, 1963). DNA content was slightly increased above 
controls indicating increased mammogenesis. 
The effect of hydrocortisone in combination with estrogen-
progesterone is dependent on the quantity administered. The principal 
effect of 62.5 yg of hydrocortisone was mammogenesis. Both mammo-
genic and secreLory effects, e.g., increases in DNA, RMA and litter 
weight, were induced by 125 yg of hydrocortisone. The mammary glands 
of 250 ng hydrocortisone treated animals were highly secretory. 
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Thyroxine, estrogens and progesterone have been shown to enhance 
the binding capacity of CBG (Gala and V/estphal, I965). This could 
partly explain the depression of milk secretion by estrogen-
progesterone. If larger quantities of glucocorticoids are bound to 
CBG decreasing the amount of free glucocorticoids, lactational 
performance could then be hindered. Lyons et al. (1953) demonstrated 
that prolactin and glucocorticoids are the minimal requirements for 
the maintenance of lactation in the rat. Yet, there must be a 
minimum level of glucocorticoid which is sufficient. it is con­
ceivable then that the amount of free glucocorticoid could be reduced 
to near or below this critical level depressing milk secretion. 
This could possibly explain how 250 yg of hydrocortisone 
was able to override the suppressive effects of estrogen-progesterone 
on lactation and lower quantities were not. This quantity of hydro­
cortisone could saturate the binding sites of CBG, while simultaneous­
ly increasing the amount of free glucocorticoid. Also, exogenous 
glucocorticoids have been shown to depress the binding capacity of 
rat plasma (Gala and Westphal, 1967). The antagonistic actions of 
estrogen-progesterone and glucocorticoids on binding capacity of rat 
plasma could be shifted in favor of the glucocorticoid effects by 
250 yg of hydrocortisone acetate. 
Estrogen-progesterone plus prolactin treatments induced 
changes in litter weights, nucleic acid content and RNA/DNA ratio 
similar to EP plus 125 wg hydrocortisone. Inadequate quantities 
of glucocorticoid somehow prevent normal milk secretion. When 250 yg 
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hydrocortisone is combined with EPL, litter weights are normal 
and RNA/DNA ratio is significantly elevated above controls or 
estrogen-progesterone prolactin treated animals. 
Litter growth was, in fact, enhanced by reducing the amount 
of prolactin to .25 mg given in combination with EP plus 
hydrocortisone. This is not to say that prolactin is not 
important in the initiation and maintenance of milk secretion. 
Meites et al. (1969) showed that progesterone, testosterone propionate 
and Cortisol acetate injections into rats increased pituitary pro­
lactin concentrations and promoted mammary development. This 
reduced quantity of prolactin could be insufficient to inhibit 
pituitary prolactin release stimulated by the other hormones. The 
concentrations and ratios of prolactin-glucocorticoid may then 
become optimum for maximal milk secretion. In support of this idea 
is the high mortality rate of pups of dams treated with estrogen-
progesterone plus 2 mg of prolactin (unpublished research of L. 
Haynes and D. R. Griffith). This quantity of prolactin was not 
able to override the inhibitory effects of estrogen-progesterone. 
Chen and Meites (1970) and Kalra et al. (1973) observed increased 
prolactin secretion after treatment of rats with estrogen, progesterone 
or estrogen-progesterone. Treatment of animals with estrogen-
progesterone plus quantities of prolactin greater than 1 mg may 
increase plasma prolactin levels to the point that prolactin-
glucocorticoid ratios or absolute quantities are upset thus 
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depressing lactation. More research is needed to determine optimum 
prolactin-glucocorticoid ratios for normal lactation. 
Lactational performance was increased by injections of 250 U9 
hydrocortisone acetate. Litter weights, RNA and RNA/DNA ratio were 
significantly increased above controls. These results were cbta: r.ed 
without the loss in weight of the dams reported by Johnson and 
Meites (195S) with 1 mg of Cortisol acetate. 
DNA content was unaffected by 5~hydroxytryptophan treatments. 
RNA content and RNA/DNA ratio were significantly increased but litter 
weights were below normal. The mechanism(s) by which 5HTP exerts 
its effects is unknown. 
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SUMMARY 
The ability of hydrocortisone acetate and/or prolactin to 
override the suppressive effects of estrogen-progesterone treatments 
on lactation was studied. Mammary gland growth was measured by DNA 
content and secretory activity was estimated from RNA content, 
RNA/DNA ratio and litter weight gains. 
Estrogen-progesterone treatments suppressed litter weight 
gains, RNA content and RNA/DNA ratio while simultaneously elevating 
total DNA content. 
A dose-response relationship was observed between the amount 
of hydrocortisone administered in combination with estrogen-proges­
terone and litter weight gains. Litters of dams receiving the 
largest dose of hydrocortisone were equal in size to controls. 
Administration of 125 ug and 250 vg of hydrocortisone acetate 
increased RNA content and RNA/DNA ratio above that of animals 
receiving estrogen-progesterone alone. increased litter weights 
coincided with these increases in nucleic acid parameters. The 
low dose of hydrocortisone, 62.5 ug, was not able to override the 
estrogen-progesterone effects on DNA, RNA, RNA/DNA ratio or litter 
size. 
Two hundred-fifty yg of hydrocortisone alone decreased DUA and 
increased RNA, RNA/DNA ratio and litter weight gains. The slope 
of litter growth curves of 250 yg hydrocortisone treated animals 
was higher than those of all experimental groups except those of 
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animals receiving 1 mg of prolactin alone. 
Prolactin alone increased DNA content above that of control 
animals and those receiving 250 yg of hydrocortisone alone. 
However, hydrocortisone was a more effective stimulator of RNA, 
RNA/DNA ratio and litter growth. 
When prolactin or hydrocortisone was given in conjunction 
with estrogen-progesterone, their effects were similar; slight 
increase in DNA and significant increase in RNA, RNA/DNA ratio and 
slopes of litter growth curves. When both prolactin and hydrocortisone 
were given simultaneously with estrogen-progesterone, there was a 
negligible increase in DNA but highly significant increases in RNA, 
RNA/DNA ratio and slopes of litter growth curves. Litter weights 
in this group were equal to controls. These effects were potentiated 
by ovariectomizing dams. 
5HTP elevated RNA content and RNA/DNA ratio above controls and 
of animals receiving prolactin. Litter weights of 5HTP animals were 
below both control and prolactin animals. The mechanism(s) by which 
5HTP exerted its effects is unknown. Its effects on RNA and RNA/DNA 
ratio could possibly be mediated by increased prolactin release, and 
its detrimental effects on litter growth could be due to the 
chemical itself occurring in the milk. 
The general observation rroiïi Liiis study is that either 250 yg 
of hydrocortisone acetate or 1 mg of prolactin is sufficient to 
overcome the suppressive effects of estrogen-progesterone treatments. 
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However, a combination of the two induces a greater response in 
terms of nucleic acid synthesis, RNA/DNA ratio and litter growth 
rates. Ovariectomy enhances these effects. 
The specific observations are: 
1. Estrogen-progesterone treatment of lactating rats reverts the 
lactating mammary gland to the pregnant or non-secretory state. 
2. The effects of hydrocortisone acetate are dependent on the 
quantity administered: 62.5 pg induced mammogenesis, 125 yg 
induced both mammogenesis and galactopoiesis and 250 yg induced 
galactopoiesi s. 
3. The mechanism by which glucocorticoids override the inhibitory 
effects of estrogen-progesterone on lactation is probably through 
changes in the binding capacity of plasma. 
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